IRAK1 and systemic lupus erythematosus: This may be attributed to the correlation among SNPs in miRNA‐146a and its target gene, interleukin‐1 receptor‐associated kinase 1 (IRAK1), and disease susceptibility, clinical manifestations, and disease progression in patients with SLE.